Tag #R&D Investment

Showing 1 to 8 of 8 results

africa.chinadaily.com.cn

🌐 85% Global Worthiness

Aug 25, 07:17

China Invests Heavily in Tech to Drive Global Competitiveness

China's 2024 R&D expenditure exceeded \$502.3 billion, reflecting President Xi Jinping's emphasis on "new quality productive forces" through technological innovation to boost global competitiveness, drive economic growth, and solidify its position as a global innovation leader.

China Invests Heavily in Tech to Drive Global Competitiveness

China's 2024 R&D expenditure exceeded \$502.3 billion, reflecting President Xi Jinping's emphasis on "new quality productive forces" through technological innovation to boost global competitiveness, drive economic growth, and solidify its position as a global innovation leader.

Progress

48% Bias Score

ShareSaveArticle

Industry, Innovation, and Infrastructure

12345678

Previous 1 of 8 Next

How does China's strategy of fostering "new quality productive forces" address both domestic economic challenges and global technological competition?

This initiative connects China's economic strategy to global technological competition and economic growth. By prioritizing technological innovation and R&D investment, China seeks to establish a dominant position in strategic emerging fields. This strategy leverages the country's large domestic market, talent pool, and existing industrial base to drive innovation and economic expansion.

lemonde.fr

🌐 85% Global Worthiness

Jun 5, 13:13

Draghi Report: Europe's Technological Lag and the Need for Massive Investment

Mario Draghi's September 2024 report to the European Commission reveals a significant technological gap between Europe and the US, caused by chronic underinvestment in R&D (€270 billion less in 2021), recommending a substantial increase in European investment (€750-800 billion annually) and regulato...

Draghi Report: Europe's Technological Lag and the Need for Massive Investment

Mario Draghi's September 2024 report to the European Commission reveals a significant technological gap between Europe and the US, caused by chronic underinvestment in R&D (€270 billion less in 2021), recommending a substantial increase in European investment (€750-800 billion annually) and regulato...

Progress

44% Bias Score

ShareSaveArticle

Decent Work and Economic Growth

12345678

Previous 1 of 8 Next

How does Draghi's proposed increase in public investment aim to foster sustainable, inclusive, and innovation-driven growth in Europe?

Draghi's report attributes Europe's lower productivity to underinvestment in research and development, resulting in a significant technological gap compared to the US and China. He recommends increasing European investment to €750-800 billion annually (4.4-4.7% of GDP) to address this.

politico.eu

🌐 85% Global Worthiness

May 20, 07:12

Europe's Pharmaceutical Legislation: A Critical Juncture

Europe's pharmaceutical industry faces a critical decision regarding the General Pharmaceutical Legislation (GPL), with potential risks to its competitiveness and patient access to new treatments if it fails to modernize its regulatory framework, given that Europe's share of global R&D investment ha...

Europe's Pharmaceutical Legislation: A Critical Juncture

Europe's pharmaceutical industry faces a critical decision regarding the General Pharmaceutical Legislation (GPL), with potential risks to its competitiveness and patient access to new treatments if it fails to modernize its regulatory framework, given that Europe's share of global R&D investment ha...

Progress

60% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How do proposed changes to intellectual property rights and reimbursement processes within the GPL impact Europe's ability to attract investment in pharmaceutical R&D?

The General Pharmaceutical Legislation (GPL) presents a critical juncture for Europe's life sciences sector. Failure to modernize regulations risks accelerating the shift of R&D and manufacturing to other regions, particularly the US and China, which are significantly outpacing Europe in investment and innovation. The GPL's success hinges on creating a regulatory environment that attracts investment and fosters innovation.

china.org.cn

🌐 85% Global Worthiness

Apr 1, 07:18

Huawei Reports Strong 2024 Growth, Driven by R&D and Diversification

Huawei's 2024 annual report reveals 862.1 billion yuan in sales revenue, a 62.6 billion yuan net profit, and a 179.7 billion yuan investment in R&D, showcasing significant growth and diversification across AI, HarmonyOS, and automotive solutions.

Huawei Reports Strong 2024 Growth, Driven by R&D and Diversification

Huawei's 2024 annual report reveals 862.1 billion yuan in sales revenue, a 62.6 billion yuan net profit, and a 179.7 billion yuan investment in R&D, showcasing significant growth and diversification across AI, HarmonyOS, and automotive solutions.

Progress

24% Bias Score

ShareSaveArticle

Decent Work and Economic Growth

12345678

Previous 1 of 8 Next

What were the key factors driving Huawei's significant revenue growth and profitability in 2024?

In 2024, Huawei's sales revenue reached 862.1 billion yuan (approximately 120.1 billion USD), a significant increase from the previous year. This growth, exceeding forecasts, resulted in a net profit of 62.6 billion yuan.

china.org.cn

🌐 85% Global Worthiness

Jul 29, 07:15

China's Sci-Tech and Industrial Innovation Integration Yields Impressive Results

From January to May 2025, China saw nearly 5 million effective invention patent applications (up 12.8 percent year-on-year) and a 9.5 percent increase in major high-tech manufacturers' value-added industrial output, driven by robust government support, enterprise participation, and open collaboratio...

China's Sci-Tech and Industrial Innovation Integration Yields Impressive Results

From January to May 2025, China saw nearly 5 million effective invention patent applications (up 12.8 percent year-on-year) and a 9.5 percent increase in major high-tech manufacturers' value-added industrial output, driven by robust government support, enterprise participation, and open collaboratio...

Progress

44% Bias Score

ShareSaveArticle

Industry, Innovation, and Infrastructure

12345678

Previous 1 of 8 Next

What key factors drove the significant increase in China's patent applications and high-tech industrial output in the first half of 2025?

China's integration of scientific and technological innovation with industrial innovation has yielded significant results, with nearly 5 million effective invention patent applications from January to May 2025 (a 12.8 percent year-on-year increase) and a 9.5 percent rise in the value-added industrial output of major high-tech manufacturers in the first half of the year. This progress is reflected in diverse sectors, from robotics and aerospace to underwater technologies and drone development.

dailymail.co.uk

🌐 75% Global Worthiness

May 28, 04:10

UK Economic Growth Lags 25 Percent Behind Pre-Crisis Trend

The UK's economic growth is lagging 25 percent below pre-Great Financial Crisis trends due to underinvestment, skills gaps, and deteriorating health, according to the IMF, despite government initiatives.

UK Economic Growth Lags 25 Percent Behind Pre-Crisis Trend

The UK's economic growth is lagging 25 percent below pre-Great Financial Crisis trends due to underinvestment, skills gaps, and deteriorating health, according to the IMF, despite government initiatives.

Progress

52% Bias Score

ShareSaveArticle

Decent Work and Economic Growth

12345678

Previous 1 of 8 Next

What are the primary causes of the UK's sluggish economic growth, and what are their immediate consequences?

The UK's economic growth is significantly lagging, with output 25 percent below its pre-Great Financial Crisis trend. The IMF attributes this to underinvestment in R&D, limited business financing, skills gaps, and deteriorating health outcomes. Labour's government, despite some initiatives, hasn't effectively addressed these issues.

repubblica.it

🌐 75% Global Worthiness

Apr 21, 16:13

Italy's Research Paradox: Innovation Despite Underfunding

A new Italian Tech publication profiles 223 Italian research organizations, highlighting the country's scientific strengths despite its low ranking (18th of 27) in EU research and development investment—only 1.3% of GDP compared to the EU average of 2.22%—and the increasing dominance of private, mos...

Italy's Research Paradox: Innovation Despite Underfunding

A new Italian Tech publication profiles 223 Italian research organizations, highlighting the country's scientific strengths despite its low ranking (18th of 27) in EU research and development investment—only 1.3% of GDP compared to the EU average of 2.22%—and the increasing dominance of private, mos...

Progress

44% Bias Score

ShareSaveArticle

Industry, Innovation, and Infrastructure

12345678

Previous 1 of 8 Next

How does the increasing dominance of private, primarily US-based, funding in scientific research impact Italy's ability to compete globally?

The article contrasts Italy's low public investment in research and development (R&D) with the abundance of innovative projects within the country. This discrepancy emphasizes the need for increased public funding to support and expand Italy's scientific capabilities and its role in the global economy. The shift towards private R&D funding, largely dominated by US companies, further underscores this challenge.

africa.chinadaily.com.cn

🌐 85% Global Worthiness

Mar 24, 04:09

AstraZeneca Invests $2.5 Billion in Beijing R&D Center

AstraZeneca is investing $2.5 billion in Beijing to establish its sixth global R&D center, partnering with three Chinese biotech companies and the Beijing Cancer Hospital, aiming to leverage China's life sciences ecosystem and expand its global reach.

AstraZeneca Invests $2.5 Billion in Beijing R&D Center

AstraZeneca is investing $2.5 billion in Beijing to establish its sixth global R&D center, partnering with three Chinese biotech companies and the Beijing Cancer Hospital, aiming to leverage China's life sciences ecosystem and expand its global reach.

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How will the partnerships with Chinese biotech companies and the Beijing Cancer Hospital contribute to AstraZeneca's research and development efforts?

The investment reflects AstraZeneca's commitment to China's life sciences sector and aims to leverage Beijing's AI and data science capabilities to advance early-stage research and clinical development. The collaborations with local biotech companies will focus on antibody discovery, macro-cyclic peptide development, and vaccine manufacturing.

Showing 1 to 8 of 8 results